Carregant...
Evidences for the Anti-panic Actions of Cannabidiol
BACKGROUND: Panic disorder (PD) is a disabling psychiatry condition that affects approximately 5% of the worldwide population. Currently, long-term selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for PD; however, the common side-effect profiles and drug interactions may...
Guardat en:
| Publicat a: | Curr Neuropharmacol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Bentham Science Publishers
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5412699/ https://ncbi.nlm.nih.gov/pubmed/27157263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666160509123955 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|